Muskarinski acetilholinski receptor M4 (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Muskarinski acetilholinski receptor M4" in Serbian language version.
refsWebsite
Global rank
Serbian rank
5,673rd place
7,382nd place
doi.org
- Grewal RP, Martinez M, Hoehe M, Bonner TI, Gershon ES, Detera-Wadleigh S (1992). „Genetic linkage mapping of the m4 human muscarinic receptor (CHRM4)”. Genomics. 13 (1): 239—40. PMID 1577490. doi:10.1016/0888-7543(92)90236-L.
- Jeon J; Dencker D; Wörtwein G; et al. (2010). „A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors”. J. Neurosci. 30 (6): 2396—405. PMC 2824442
. PMID 20147565. doi:10.1523/JNEUROSCI.3843-09.2010. - Schmidt L. S.; Thomsen M.; Weikop P.; Dencker D.; Wess J. R.; Woldbye D. P. D.; Wortwein G.; Fink-Jensen A. (2011). „Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice”. Psychopharmacology. 216 (3): 367—378. PMID 21373792. doi:10.1007/s00213-011-2225-4.
- Langmead CJ, Watson J, Reavill C (2008). „Muscarinic acetylcholine receptors as CNS drug targets”. Pharmacology & Therapeutics. 117 (2): 232—43. PMID 18082893. doi:10.1016/j.pharmthera.2007.09.009.
- Stein IS, Hell JW (2010). „CaMKII hunkers down on the muscarinic M4 receptor to help curb cocaine-induced hyperlocomotion”. The EMBO Journal. 29 (12): 1943—5. PMC 2892364 . PMID 20551968. doi:10.1038/emboj.2010.105.
- Chan WY; McKinzie DL; Bose S; et al. (2008). „Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia”. PNAS. 105 (31): 10978—83. PMC 2495016 . PMID 18678919. doi:10.1073/pnas.0800567105.
- Brady AE; Jones CK; Bridges TM; et al. (2008). „Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats”. J. Pharmacol. Exp. Ther. 327 (3): 941—53. PMC 2745822 . PMID 18772318. doi:10.1124/jpet.108.140350.
- Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK (2005). „Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies”. Behavioural Brain Research. 161 (2): 299—305. PMID 15922057. doi:10.1016/j.bbr.2005.02.019.
nih.gov
ncbi.nlm.nih.gov
- „Entrez Gene: CHRM4 cholinergic receptor, muscarinic 4”.
- Grewal RP, Martinez M, Hoehe M, Bonner TI, Gershon ES, Detera-Wadleigh S (1992). „Genetic linkage mapping of the m4 human muscarinic receptor (CHRM4)”. Genomics. 13 (1): 239—40. PMID 1577490. doi:10.1016/0888-7543(92)90236-L.
- Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, Wess J (1999). „Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice”. Proceedings of the National Academy of Sciences of the United States of America. 96 (18): 10483—8. PMC 17915 . PMID 10468635.
- Jeon J; Dencker D; Wörtwein G; et al. (2010). „A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors”. J. Neurosci. 30 (6): 2396—405. PMC 2824442 . PMID 20147565. doi:10.1523/JNEUROSCI.3843-09.2010.
- Schmidt L. S.; Thomsen M.; Weikop P.; Dencker D.; Wess J. R.; Woldbye D. P. D.; Wortwein G.; Fink-Jensen A. (2011). „Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice”. Psychopharmacology. 216 (3): 367—378. PMID 21373792. doi:10.1007/s00213-011-2225-4.
- Langmead CJ, Watson J, Reavill C (2008). „Muscarinic acetylcholine receptors as CNS drug targets”. Pharmacology & Therapeutics. 117 (2): 232—43. PMID 18082893. doi:10.1016/j.pharmthera.2007.09.009.
- Stein IS, Hell JW (2010). „CaMKII hunkers down on the muscarinic M4 receptor to help curb cocaine-induced hyperlocomotion”. The EMBO Journal. 29 (12): 1943—5. PMC 2892364 . PMID 20551968. doi:10.1038/emboj.2010.105.
- Guo ML, Mao LM, Wang JQ (2010). „Modulation of M4 muscarinic acetylcholine receptors by interacting proteins”. Neuroscience Bulletin. 26 (6): 469—73. PMC 3139403 . PMID 21113197.
- Chan WY; McKinzie DL; Bose S; et al. (2008). „Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia”. PNAS. 105 (31): 10978—83. PMC 2495016 . PMID 18678919. doi:10.1073/pnas.0800567105.
- Brady AE; Jones CK; Bridges TM; et al. (2008). „Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats”. J. Pharmacol. Exp. Ther. 327 (3): 941—53. PMC 2745822 . PMID 18772318. doi:10.1124/jpet.108.140350.
- Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK (2005). „Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies”. Behavioural Brain Research. 161 (2): 299—305. PMID 15922057. doi:10.1016/j.bbr.2005.02.019.
- Lazareno S, Buckley NJ, Roberts FF (1990). „Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells”. Molecular Pharmacology. 38 (6): 805—15. PMID 2250662.